# Atrium Therapeutics (RNA) — Overview

RNA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rna

## Price

Last close $7.82 on Oct 15, 2026. 52-week range $7.68 – $16.54.

## Company profile

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $35.8M |
| Revenue (quarter) | $3.0M |
| Revenue growth (year over year) | -21.91% |
| Gross profit (trailing twelve months) | $35.8M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$66.0M |
| Net income (quarter) | −$20.2M |
| Net income growth (year over year) | -56.74% |
| Net margin | -184.14% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | $0.00 |
| Book value per share | $12.54 |
| P/E (trailing twelve months) | — |
| Price to book | 0.6 |
| Debt to assets | 23.51% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Atrium Therapeutics (RNA) profitable?

No. Atrium Therapeutics reported a net loss of $66.0M over the trailing twelve months.

### How much revenue does Atrium Therapeutics (RNA) make?

Atrium Therapeutics generated $35.8M in revenue over the trailing twelve months, down 21.91% year over year.

### How do I buy stock in Atrium Therapeutics (RNA)?

RNA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).